Work

Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(12)70105-9

Authors: Michel Baulac, Martin J Brodie, Anna Patten, Joanna Segieth, Luigi Giorgi

Institutions: Pitié-Salpêtrière Hospital, Western Infirmary, Eisai (United Kingdom)

Language: English

Topic: Epilepsy research and treatment

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, GlaxoSmithKline, Novartis, Medtronic, Viropharma, European Commission, Eisai, Ipsen, UCB Pharma, Cilag

OpenAlex ID: W2075552514

FWCI: 12.16

Cites: 37

Cited by: 186

Related to: 10